TickerFactsScreenerDevelopers

MADRIGAL PHARMACEUTICALS, INC. (MDGL) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $454.0K2010: $136.0K2011: $690.0K2012: $505.0K2013: $769.0K2014: $144.0K2015: $58.0K2016: $3.0K2017: $125.0K2018: $22.0K2019: $172.0K2020: $334.0K2021: $209.0K2022: $217.0K2023: $1.48M2024: $1.46M2025: $467.0K$467.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$467.0K-68.1%
2024$1.46M-1.1%
2023$1.48M+581.6%
2022$217.0K+3.8%
2021$209.0K-37.4%
2020$334.0K+94.2%
2019$172.0K+681.8%
2018$22.0K-82.4%
2017$125.0K+4066.7%
2016$3.0K-94.8%
2015$58.0K-59.7%
2014$144.0K-81.3%
2013$769.0K+52.3%
2012$505.0K-26.8%
2011$690.0K+407.4%
2010$136.0K-70.0%
2009$454.0K—